These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 16769443

  • 21. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S, Chatterjee A, Bhattacharjee S, Ray B, Saha MK, Bhattacharya SK.
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [Abstract] [Full Text] [Related]

  • 22. Sexual behaviors and seroprevalence of HIV, HBV, and HCV among hill tribe youths of Northern Thailand.
    Apidechkul T.
    BMC Public Health; 2019 Aug 14; 19(1):1101. PubMed ID: 31412838
    [Abstract] [Full Text] [Related]

  • 23. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran.
    Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland W, Banifazl M, Mostafavi E, Eslamifar A, Sofian M.
    AIDS Care; 2014 Aug 14; 26(9):1122-6. PubMed ID: 24499303
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors.
    Gyarmathy VA, Neaigus A, Ujhelyi E, Szabó T, Rácz J.
    Drug Alcohol Depend; 2006 Apr 14; 82 Suppl 1(Suppl 1):S65-9. PubMed ID: 16769448
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB, Jain S, Kuramoto IK, Richards C, Sazama K, Samuels S, Holland PV, Flynn N.
    West J Med; 1992 Jan 14; 156(1):30-5. PubMed ID: 1310362
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Jan 14; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 32. HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil.
    de Carvalho HB, Mesquita F, Massad E, Bueno RC, Lopes GT, Ruiz MA, Burattini MN.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May 01; 12(1):84-92. PubMed ID: 8624766
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B, Nielsen S, Gassowski M, Santos-Hövener C, Cai W, Ross RS, Bock CT, Ratsch BA, Kücherer C, Bannert N, Bremer V, Hamouda O, Marcus U, Zimmermann R, DRUCK Study group.
    BMC Public Health; 2016 Sep 05; 16(1):927. PubMed ID: 27595567
    [Abstract] [Full Text] [Related]

  • 35. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, Costa C, Masciari R, Naso E, Biselli R.
    J Clin Lab Immunol; 1995 Sep 05; 47(1):1-9. PubMed ID: 8735431
    [Abstract] [Full Text] [Related]

  • 36. Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia.
    Abdala N, Krasnoselskikh TV, Durante AJ, Timofeeva MY, Verevochkin SV, Kozlov AP.
    Eur Addict Res; 2008 Sep 05; 14(1):19-25. PubMed ID: 18182769
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, Sedaghat A, Ono-Kihara M, Kihara M.
    Int J Drug Policy; 2010 Nov 05; 21(6):493-500. PubMed ID: 20483578
    [Abstract] [Full Text] [Related]

  • 38. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L, Chant K, Jalaludin B, Sargent P.
    J Gastroenterol Hepatol; 2004 Oct 05; 19(10):1114-20. PubMed ID: 15377287
    [Abstract] [Full Text] [Related]

  • 39. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S, Roy T, Pahari S, Mehraa J, Sharma N, Singh G, Singh J, Joseph F, Singh S, Sharma NM.
    Int J STD AIDS; 2014 Jul 05; 25(8):596-606. PubMed ID: 24352120
    [Abstract] [Full Text] [Related]

  • 40. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
    Edeh J, Spalding P.
    J Public Health Med; 2000 Dec 05; 22(4):531-9. PubMed ID: 11192282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.